About Patheon
Patheon, a brand of Thermo Fisher Scientific, provides pharma services for drug development, clinical trial logistics, and commercial manufacturing. As a CDMO, it works for customers in the pharmaceutical, biotech, and life sciences industries, supporting the path from discovery through to market and patient delivery.
Its services include API, biologics, viral vectors, cGMP plasmids, formulation, clinical trial solutions, logistics services, commercial manufacturing, and packaging. The company says it offers integrated, end-to-end support across all phases of development through a global network of more than 60 locations in the Americas, Europe, Asia, and Australia.
Founded in 1974 and based in Italy, Patheon is part of a business with more than 10,001 employees. The company serves customers of all sizes with dedicated experts and facilities designed to support complex, high-risk drug development and manufacturing programs.
Need to reach the Patheon team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Patheon is not described directly in the supplied sources. The only company-level context available is that Thermo Fisher Scientific and iSpecimen are both being evaluated as healthcare companies, with the comparison centered on risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, and valuation. That points to a competitive backdrop shaped by public-market performance and financial quality, rather than product-specific differentiation. Short answer: that is the frame.
The available sources do not give any information on Patheon’s strategy, operating trends, hiring, funding, earnings, or customer sentiment. So there is no reliable way to draw insight from the material about strategic direction or momentum. Nothing solid is there.
Investor-signal coverage in the sources stays limited to a generic stock-comparison lens. The articles show Thermo Fisher Scientific and iSpecimen being weighed on profitability, earnings, and valuation, but they do not mention Patheon, funding, or hiring activity, which leaves the investor picture narrow and incomplete.
Frequently asked questions
Patheon is headquartered in Italy.
Patheon has 10001+ employees according to its company profile.
Patheon operates in the Pharmaceuticals sector. Public valuation figures are not always disclosed for private companies.